Repligen (RGEN) Asset Writedowns and Impairment (2012 - 2015)
Repligen (RGEN) posted quarterly Asset Writedowns and Impairment of -$21902.0 for Q3 2015, up 59.42% quarter-over-quarter from -$53974.0 in Q1 2013.
Repligen (RGEN) Asset Writedowns and Impairment (2012 - 2015) Analysis & Trends
Repligen (RGEN) has reported Asset Writedowns and Impairment for 3 consecutive years, with -$21902.0 the latest figure, recorded in Q3 2015.
- In Q3 2015, Asset Writedowns and Impairment changed N/A year-over-year to -$21902.0; the TTM figure through Sep 2015 stood at $466125.0 (changed N/A YoY), while the FY2013 annual figure was $91191.0, down 84.91% from the prior year.
- Asset Writedowns and Impairment improved to -$21902.0 in Q3 2015 per RGEN's latest filing, from -$53974.0 in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $277301.0 in Q3 2012 and bottomed at -$53974.0 in Q1 2013.
- Historically, Asset Writedowns and Impairment has averaged $116531.2 across 3 years, with a median of $121399.0 in 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Repligen | 10.25 Bn | 9.24 Bn | 110.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2015 | -21,902.00 |
| Sep 30, 2015 | -21,902.00 |
| Mar 31, 2013 | -53,974.00 |
| Mar 31, 2013 | -53,974.00 |
| Dec 31, 2012 | 264,700.00 |
| Dec 31, 2012 | 264,700.00 |
| Sep 30, 2012 | 277,301.00 |
| Sep 30, 2012 | 277,301.00 |